The European Cannabis Report: 10th Edition
The European Cannabis Report: 10th Edition
Market sizing forecasts (spreadsheet format) for 31 European countries, broken down by year (2025-2029). This package also includes medical cannabis patient population forecasts for all 31 countries, as well as a written market sizing analysis.Â
In addition, you’ll receive exclusive, first-look access to the new-style digital version of the Report prior to its official launch.
Market sizing forecasts (spreadsheet format) for all three legal markets in Europe (Medical, Adult-Use & CBD), broken down by year (2025-2029). This includes:Â
- Medical Market Sizing & Patient Population Forecasts - Raw medical market sizing forecasts (spreadsheet format) for 31 European countries, broken down by year (2025-2029). Medical cannabis patient population forecasts for all 31 countries.
- Adult-Use Market Sizing - Raw adult-use market sizing forecasts (spreadsheet format) for adult-use markets in Germany, Switzerland and the Netherlands, broken down by year (2025-2029).
- CBD Market Sizing - Raw CBD market sizing forecasts (spreadsheet format) for 29 European countries, broken down by year (2025-2029).
In addition, you’ll receive a written analysis of market size and exclusive first-look access to the new-style digital version of the Report prior to its official launch.Â
All of the above market sizing data and analysis, plus a two-hour market intelligence briefing consultation with a senior Prohibition Partners analyst, covering key findings from the report plus bespoke insights.Â
An extensive analysis of the medical products available to patients in Europe, and the cost to patients. This dataset covers products in key medical markets like Germany and the UK.Â
The most updated recent and historical data available on imports and exports in key cannabis markets across Europe.
For brands looking for consistent exposure in the European cannabis industry, without deep content integration or investment. This is a one-off opportunity for your brand to be associated with the 10th Edition of the most respected and longest-standing publication on the European cannabis industry.Â
Benefits Include:
- 12-Month Banner Advertising
- Branded Digital Presence – Logo featured on report homepage
- Clickable half-page ad in A key section.
- Logo featured in the ‘Thank You to Sponsors’ email
- Co-branded social media assets for your channels
- Featured social partner spotlight (LinkedIn, Twitter, Instagram – 125K+ audience)
- Full Market Sizing Package
The European Cannabis Report: 10th Edition offers the latest insights and in-depth analysis on the current landscape and development of 31 key cannabis markets across Europe.
This comprehensive report explores geographical regions within the European cannabis industry, leveraging a wide range of data sources, including Prohibition Partners’ proprietary market sizing data and analysis.
For each country, the report examines:
- Regulations
- Patient Access
- Products & Pricing
- Imports & Exports
- Domestic Production
The 31 countries covered in the report include:
- Germany
- United Kingdom
- France
- Italy
- Poland
- Switzerland
- Spain
- Croatia
- Austria
- Luxembourg
- Sweden
- Portugal
- Netherlands
- Malta
- Belgium
- Denmark
- Czechia
- Greece
- Romania
- North Macedonia
- Finland
- Slovakia
- Lithuania
- Cyprus
- Slovenia
- Norway
- Albania
- Latvia
- Estonia
- Ireland
- Ukraine
The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to The European Cannabis Report: 10th Edition.
Germany continues to lead the European medical cannabis market, now valued at over €670 million, thanks to the transformative MedCanG law enacted in April 2024. By removing cannabis from the narcotics list and eliminating bureaucratic hurdles, Germany has created Europe’s most open medical cannabis ecosystem. The market is now supported by over 20 telemedicine clinics, a robust import and distribution network, and falling flower prices, further boosting accessibility.
The Czech Republic and Denmark are establishing themselves as rising European exporters. Czech reforms have enabled commercial cultivation and a significant increase in exports – over 1,300 kg of medical cannabis was shipped to Germany in 2024. In Denmark, a decision to make its pilot programme permanent has cemented the country’s role as a major exporter, with over 7 tonnes sent to Germany in 2024 alone.
Poland is now Europe’s fourth-largest market, projected at €72 million in 2025. Recent regulatory improvements, product approvals, and telemedicine adoption spurred rapid growth, although a 2024 ban on online-first consultations has introduced new friction.
In the UK, the medical cannabis market—entirely private—is expected to exceed €300 million in 2025. Over 30 telehealth platforms serve a rapidly expanding patient base, although high treatment prices and a lack of public reimbursement remain key challenges. Domestic production is ramping up, with several UK-based producers now supplying locally cultivated cannabis.
Meanwhile, Italy remains tightly regulated, with state-controlled cultivation and procurement largely restricting market growth. Despite being one of the first movers in Europe, the market remains dominated by a few suppliers, led by Bedrocan.
Across the continent, flowers remain the dominant product format, but oils, extracts, and even vape cartridges are gaining traction—especially in markets like Germany and the UK. Canadian, Portuguese, and Danish producers continue to dominate exports into the region.
As Europe edges closer to harmonised frameworks and broader patient access, the medical cannabis sector is poised for continued acceleration, potentially surpassing €1.5 billion in combined value across leading markets by the end of the decade.
Medical Cannabis Market Sizing & Patient Population Forecasts (2025-2029)
£1,429Â
Market sizing forecasts (spreadsheet format) for 31 European countries, broken down by year (2025-2029). This package also includes medical cannabis patient population forecasts for all 31 countries, as well as a written market sizing analysis.Â
In addition, you’ll receive exclusive, first-look access to the new-style digital version of the Report prior to its official launch.Â
Full Market Sizing - Medical, Adult-Use & CBD (2025-2029)
£1,849
Market sizing forecasts (spreadsheet format) for all three legal markets in Europe (Medical, Adult-Use & CBD), broken down by year (2025-2029). This includes:Â
- Medical Market Sizing & Patient Population Forecasts - Raw medical market sizing forecasts (spreadsheet format) for 31 European countries, broken down by year (2025-2029). Medical cannabis patient population forecasts for all 31 countries.
- Adult-Use Market Sizing - Raw adult-use market sizing forecasts (spreadsheet format) for adult-use markets in Germany, Switzerland and the Netherlands, broken down by year (2025-2029).
- CBD Market Sizing - Raw CBD market sizing forecasts (spreadsheet format) for 29 European countries, broken down by year (2025-2029).
In addition, you’ll receive a written analysis of market size and exclusive first-look access to the new-style digital version of the Report prior to its official launch.Â
Full Market Sizing (2025-2029), Analysis & Online Market Intelligence Briefing
£2,839
All of the above market sizing data and analysis, plus a two-hour market intelligence briefing consultation with a senior Prohibition Partners analyst, covering key findings from the report plus bespoke insights.Â
European Medical Cannabis Products - Pricing & Analysis
£1,969
An extensive analysis of the medical products available to patients in Europe, and the cost to patients. This dataset covers products in key medical markets like Germany and the UK.
European Imports & Exports Dataset
£1,819
The most updated recent and historical data available on imports and exports in key cannabis markets across Europe.Â
Report Sponsorship (Bronze)
£6,000
For brands looking for consistent exposure in the European cannabis industry, without deep content integration or investment. This is a one-off opportunity for your brand to be associated with the 10th Edition of the most respected and longest-standing European cannabis industry publication.Â
Benefits Include:
- 12-Month Banner Advertising
- Branded Digital Presence – Logo featured on report homepage
- Clickable half-page ad in A key section.
- Logo featured in the ‘Thank You to Sponsors’ email
- Co-branded social media assets for your channels
- Featured social partner spotlight (LinkedIn, Twitter, Instagram – 125K+ audience)
- Full Market Sizing Package
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.













